Mona Ahmed Mohamed
Lecturer
Significance of AXL Expression in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (an Immunohistochemical Study)
• 2025
Publication Information
Authors
Ebtehal M. Abdel-Aala , Nehal S. Abd El Wahaba, Heba M. Rashada ,
Mona A. Aboelkheira, Shrouk E. Gamila, Shaymaa S. Ahmedb
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Chronic pancreatitis is a well-established risk
factor
pancreatic
cancer.
Pancreatic
ductal
adenocarcinoma is the most common histo-type of
pancreatic cancer and considered the third leading cause of
cancer deaths in the US. Different markers were used as
diagnostic methods for PDAC as CA19-9 which have low
sensitivity and specificity. AXL is a receptor tyrosine
kinase (RTK) belonging to the tumor-associated
macrophage (TAM) protein family that is involved in
tumorigenesis and progression of many cancers. Aim: To
evaluate the significance of (AXL) expression in chronic
pancreatitis & PDAC and to compare & correlate (AXL)
expression with the available clinicopathological data.
Material and methods: This is a retrospective study using
microarray technique carried upon selected formalin-fixed
paraffin-embedded biopsy specimens of 50 PDAC cases
and 10 cases of chronic pancreatitis. Clinicopathological
characteristics of the examined cases were correlated with
immunohistochemistry of AXL. Results: There is a
significant statistical correlation between PDAC and
chronic pancreatitis as regard expression of AXL with more
frequency of positive expression among carcinoma cases
(P=0.002). There is a significant statistical correlation
between AXL scoring and different histological grade of
studied cases, tumor necrosis, perineural invasion and TNM
stage of pancreatic ductal adenocarcinoma (P value= 0.001,
0.006, 0.002 and P=0.05 respectively). Conclusion: The
expression of AXL is more in PDAC than chronic
pancreatitis cases indicating that AXL could have a role in
the development of PDAC. AXL showed a significant
correlation with tumor grade, tumor necrosis, with
sensitivity 84%, specificity 90% and accuracy 89%.
factor
pancreatic
cancer.
Pancreatic
ductal
adenocarcinoma is the most common histo-type of
pancreatic cancer and considered the third leading cause of
cancer deaths in the US. Different markers were used as
diagnostic methods for PDAC as CA19-9 which have low
sensitivity and specificity. AXL is a receptor tyrosine
kinase (RTK) belonging to the tumor-associated
macrophage (TAM) protein family that is involved in
tumorigenesis and progression of many cancers. Aim: To
evaluate the significance of (AXL) expression in chronic
pancreatitis & PDAC and to compare & correlate (AXL)
expression with the available clinicopathological data.
Material and methods: This is a retrospective study using
microarray technique carried upon selected formalin-fixed
paraffin-embedded biopsy specimens of 50 PDAC cases
and 10 cases of chronic pancreatitis. Clinicopathological
characteristics of the examined cases were correlated with
immunohistochemistry of AXL. Results: There is a
significant statistical correlation between PDAC and
chronic pancreatitis as regard expression of AXL with more
frequency of positive expression among carcinoma cases
(P=0.002). There is a significant statistical correlation
between AXL scoring and different histological grade of
studied cases, tumor necrosis, perineural invasion and TNM
stage of pancreatic ductal adenocarcinoma (P value= 0.001,
0.006, 0.002 and P=0.05 respectively). Conclusion: The
expression of AXL is more in PDAC than chronic
pancreatitis cases indicating that AXL could have a role in
the development of PDAC. AXL showed a significant
correlation with tumor grade, tumor necrosis, with
sensitivity 84%, specificity 90% and accuracy 89%.